UN health agency urges oversight of human gene-editing research and calls for whistleblowing mechanism
The World Health Organization is moving to take a lead role in regulating global work on human gene editing, including pushing for a whistleblowing mechanism for rogue research after a two-year deep dive into the controversial technology.
In 2019, the UN’s health agency convened a panel on the subject in the wake of explosive claims that twin babies in China had been genetically modified to make them resistant to HIV. In July of that year, the panel recommended it would be “irresponsible” to undertake any clinical applications of human gene editing that affect the germline and would therefore be passed on to future generations.